Cargando…
Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
BACKGROUND: Dalbavancin is a lipoglycopeptide antibiotic approved for treatment of skin and soft tissue infections, administered as a single or two-dose treatment. The extended half-life, good penetration into bone and synovial fluid, and bactericidal activity against gram-positive bacteria, includi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588017/ https://www.ncbi.nlm.nih.gov/pubmed/37858087 http://dx.doi.org/10.1186/s12879-023-08709-8 |